SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Piper Jaffray Reiterates Overweight on Eidos Therapeutics, Raises Price Target to $75

Piper Jaffray reiterates Eidos Therapeutics (NASDAQ:EIDX) with a Overweight and raises the price target from $55 to $75.

Benzinga · -

Piper Jaffray reiterates Eidos Therapeutics (NASDAQ:EIDX) with a Overweight and raises the price target from $55 to $75.